ProfileGDS5678 / 1445217_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 27% 27% 26% 25% 27% 27% 27% 26% 25% 26% 26% 27% 26% 27% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.651127
GSM967853U87-EV human glioblastoma xenograft - Control 22.6124727
GSM967854U87-EV human glioblastoma xenograft - Control 32.6082426
GSM967855U87-EV human glioblastoma xenograft - Control 42.5353525
GSM967856U87-EV human glioblastoma xenograft - Control 52.5774527
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6994727
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.6590427
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5862526
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5616625
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5890526
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5980626
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5884327
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6078426
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.604427